Regeneron Pharmaceuticals
REGN
$978.21
Share price
-0.65%
Change (1 day)
30.26%
Change (1 year)
Categories
Earnings for Regeneron Pharmaceuticals (REGN)
Earnings in 2023 (TTM): $4.19 B
According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $4.04 B. In 2022 the company made an earning of $4.85 B a decrease over its 2021 earnings that were of $9.32 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Regeneron Pharmaceuticals from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $4.19 B | -13.57% |
| 2022 | $4.85 B | -47.9% |
| 2021 | $9.32 B | 144.75% |
| 2020 | $3.81 B | 56.86% |
| 2019 | $2.42 B | -4.87% |
| 2018 | $2.55 B | 22.86% |
| 2017 | $2.07 B | 56.3% |
| 2016 | $1.32 B | 8.55% |
| 2015 | $1.22 B | 54.53% |
| 2014 | $0.79 B | 11.14% |
| 2013 | $0.71 B | 72.13% |
| 2012 | $0.41 B | -285.93% |
| 2011 | -$0.23 B | 121.73% |
| 2010 | -$0.11 B | 37.18% |
| 2009 | -$73.28 M | -14.6% |
| 2008 | -$85.82 M | -25.02% |
| 2007 | -$0.12 B | 6.32% |
| 2006 | -$0.11 B | -186.52% |
| 2005 | $0.12 B | 2103.7% |
| 2004 | $5.64 M | -105.66% |
| 2003 | -$99.78 M | -18.18% |
| 2002 | -$0.13 B | 42.33% |
| 2001 | -$85.69 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | 428.53% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | 143.12% | 🇨🇭 Switzerland |
 Amgen AMGN | $7.85 B | 94.33% | 🇺🇸 USA |
 Sanofi SNY | $7.26 B | 79.63% | 🇫🇷 France |
 Biogen BIIB | $1.32 B | -67.26% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.2 B | -104.88% | 🇺🇸 USA |